Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Naunyn Schmiedebergs Arch Pharmacol ; 394(11): 2197-2222, 2021 11.
Article in English | MEDLINE | ID: mdl-34596729

ABSTRACT

Coenzyme Q10 (ubiquinone or CoQ10) is a lipid molecule that acts as an electron mobile carrier of the electron transport chain and also contains antioxidant properties. Supplementation of CoQ10 has been very useful to treat mitochondrial diseases. CoQ10 along with its synthetic analogue, idebenone, is used largely to treat various neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, Huntington's disease, Amyotrophic lateral sclerosis, and Friedreich's ataxia and additional brain disease condition like autism, multiple sclerosis, epilepsy, depression, and bipolar disorder, which are related to mitochondrial impairment. In this article, we have reviewed numerous physiological functions of CoQ10 and the rationale for its use in clinical practice in different brain disorders.


Subject(s)
Brain Diseases/drug therapy , Mitochondrial Diseases/drug therapy , Ubiquinone/analogs & derivatives , Animals , Antioxidants/pharmacology , Brain Diseases/physiopathology , Humans , Mitochondria/drug effects , Mitochondria/pathology , Mitochondrial Diseases/physiopathology , Neurodegenerative Diseases/drug therapy , Neurodegenerative Diseases/physiopathology , Ubiquinone/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...